References
- World Health Organization. Diabetes fact sheet. World Health Organization. Geneva, Switzerland http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed July 30, 2015
- Centers for Disease Control and Prevention. National Diabetes Statistics Report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services, 2014
- Schernthaner G, Barnett AH, Betteridge DJ, et al. IDF Diabetes Atlas Sixth Edition, 2014 Update. International Diabetes Federation, Brussels, Belgium http://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf. Accessed March 21, 2015
- Alexander GC, Sehgal NL, Moloney RM, et al. National Trends in Treatment of Type 2 Diabetes Mellitus, 1994–2007. Arch Intern Med 2008;168:2088-94
- Bertoldi AD, Kanavos P, Franca GVA, et al. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health 2013;9:62
- Huber CA, Schwenkglenks M, Rapold R, et al. Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. BMC Endocr Disord 2014;14:44
- Escghwege E, Basdevant A, Crine A, et al. Type 2 diabetes mellitus in France in 2012: Results from the ObEpi survey. Diabetes Metab 2015;14:55-61
- Karpati T, Cohen-Stavi CJ, Leibowitz M, et al. Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel. Popul Health Metr 2014;12:32
- Desai NR, Shrank WH, Fischer MA, et al. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med 2012;125:302.e1-302.37
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-46
- American Diabetes Association. Statistics about diabetes: data from the National Diabetes Statistics Report. 2014. Alexandria, VA http://www.diabetes.org/diabetes-basics/statistics/?loc=superfooter. Accessed March 21, 2015
- Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 Years, United States, 1980-2012. JAMA 2014;312:1218-26
- Weng W, Liang M, Kimball E, et al. Decreasing incidence of Type 2 diabetes mellitus in the United States, 2007 to 2012: epidemiologic findings from a large US claims database. Submitted to Diab Res Clin Pract in press
- Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963-72
- Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
- Schernthaner G, et al. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia 2010;53:1258-6
- American Diabetes Association. Standards of medical care in diabetes – 2015, Approaches to glycemic management. Diabetes Care 2015;38(1 Suppl):S41-8
- International Diabetes Federation. IDF Treatment Algorithm for People with Type 2 Diabetes, 2012 update. http://www.idf.org/treatment-algorithm-people-type-2-diabetes. Accessed June 11, 2015
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615
- Dall TM, Yang W, Halder P, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care 2014;37:3172-9
- Pelletier EM, Shim B, Ben-Joseph R, et al. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. Pharmacoeconomics 2009;27:479-90
- Bron M, Guerin A, Latremouille-Viau D, et al. Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis. J Med Econ 2014;17:646-57